Livzon Pharmaceutical Group Inc vs Shanghai Fosun Pharmaceutical (Group) Co Ltd
A side-by-side look at two Chinese stocks — live quote, valuation, growth, listing venue, dual-listing and delisting status, and the WealthyTec Rank. A factual comparison for orientation, not investment advice.
| Metric | Livzon Pharmaceutical Group Inc 1513.HK · Hong Kong 25.70 HKD | Shanghai Fosun Pharmaceutical (Group) Co Ltd 2196.HK · Hong Kong 16.34 HKD |
|---|---|---|
| Day change | +1.66% | +2.32% |
| Market cap | $2.13B | $5.49B |
| P/E (TTM) | — | — |
| 2y EPS CAGR | — | — |
| WealthyTec Rank | 6.1 | 6.5 |
| Rank within sector | #11 of 31 | #10 of 31 |
| Listing venue | HKEX | HKEX |
| Other listings | n/a | n/a |
| Delisting filings | None on record | None on record |
| Sector | Health Care | Health Care |
| Industry | Biotech and Pharma | Biotech and Pharma |
Of the two, Shanghai Fosun Pharmaceutical (Group) Co Ltd currently carries the higher WealthyTec Rank (6.5 vs 6.1). The Rank reflects past revenue, earnings and EPS trends only — not valuation, momentum, or the policy and delisting risks every China investor should weigh, and it is not a recommendation to buy, sell or hold either security. See our rank methodology.